Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.

[1]  N S El Saghir,et al.  4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)† , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Daniel F. Hayes,et al.  20‐Year Risks of Breast‐Cancer Recurrence after Stopping Endocrine Therapy at 5 Years , 2017, The New England journal of medicine.

[3]  Jennifer S. Yu,et al.  Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases. , 2017, Journal of neurosurgery.

[4]  J. Beyene,et al.  Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. , 2015, International journal of radiation oncology, biology, physics.

[5]  Adrian V. Lee,et al.  Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy , 2015, Cancer medicine.

[6]  H. Linden,et al.  The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most? , 2015, Breast Cancer Research and Treatment.

[7]  C. Brennan,et al.  Outcomes and prognostic factors in women with 1 to 3 breast cancer brain metastases treated with definitive stereotactic radiosurgery. , 2014, International journal of radiation oncology, biology, physics.

[8]  F. Montemurro,et al.  Metastatic breast cancer subtypes and central nervous system metastases. , 2014, Breast.

[9]  J. Jaboin,et al.  Survival following gamma knife radiosurgery for brain metastasis from breast cancer , 2013, Radiation oncology.

[10]  J. Sheehan,et al.  Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. , 2012, International journal of radiation oncology, biology, physics.

[11]  E. Shaw,et al.  Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery , 2012, Journal of Neuro-Oncology.

[12]  Dirk Rades,et al.  Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline , 2012, Practical radiation oncology.

[13]  Jean-Philippe Spano,et al.  Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment , 2012, Radiation Oncology.

[14]  M. McDermott,et al.  Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[15]  A. Nichol,et al.  Population-based outcomes after whole brain radiotherapy and re-irradiation in patients with metastatic breast cancer in the trastuzumab era , 2011, Radiation oncology.

[16]  C. Perou,et al.  The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases , 2011, Cancer.

[17]  D. Kondziolka,et al.  Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. , 2011, Journal of neurosurgery.

[18]  F. Heitz,et al.  Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. , 2009, European journal of cancer.

[19]  M. Berger,et al.  Gamma Knife radiosurgery for brain metastases from primary breast cancer. , 2007, International journal of radiation oncology, biology, physics.

[20]  S. Hassenbusch,et al.  Stereotactic Radiosurgical Treatment of Cerebral Metastases Arising From Breast Cancer , 2007, American journal of clinical oncology.

[21]  J. Debus,et al.  Treatment of Cerebral Metastases from Breast Cancer with Stereotactic Radiosurgery , 2004, Strahlentherapie und Onkologie.

[22]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Tonn,et al.  Stereotactic radiosurgery for multiple brain metastases from breast carcinoma , 2004, Cancer.

[24]  W. Curran,et al.  Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. , 2001, International journal of radiation oncology, biology, physics.

[25]  D. Kondziolka,et al.  Stereotactic Radiosurgery for Brain Metastases From Breast Cancer , 2000, Annals of Surgical Oncology.

[26]  A. Tutt,et al.  3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). , 2017, Breast.